livehealth.store

Buprenorphine And Naloxone recalls

Buprenorphine And Naloxone products have been recalled 2 times, most recently on 9 Nov 2022. The recalling company is usually Alvogen.

Total recalls2since 2021

Last 12 months0reported

Class I00% of total

Ongoing0latest 9 Nov 2022

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why buprenorphine and naloxone is recalled

Other Reasons150%
Potency & Assay150%

Companies

Alvogen150%
Sun Pharmaceutical Industries150%

By year

2022150%
2021150%

All buprenorphine and naloxone recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
9 Nov 2022Drug	CLASS II	Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg recalledBuprenorphine And Naloxone	Sun Pharmaceutical Industries	Other	Nationwide
14 Jul 2021Drug	CLASS II	Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg recalled by AlvogenBuprenorphine And Naloxone	Alvogen	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.